Invention Grant
- Patent Title: Method for stimulating T lymphocytes with IL-2
-
Application No.: US14004211Application Date: 2012-03-09
-
Publication No.: US09669071B2Publication Date: 2017-06-06
- Inventor: David Klatzmann , David Saadoun , Patrice Cacoub , Michèle Rosenzwajg , Eliane Piaggio , Gilbert Bensimon , Claude Bernard
- Applicant: David Klatzmann , David Saadoun , Patrice Cacoub , Michèle Rosenzwajg , Eliane Piaggio , Gilbert Bensimon , Claude Bernard
- Applicant Address: FR Paris FR Paris FR Paris
- Assignee: INSERM (Institut National de la Santé et de la Recherche Médicale),Assistance Publique—Hopitaux De Paris,Universite Pierre et Marie Curie (PARIS 6)
- Current Assignee: INSERM (Institut National de la Santé et de la Recherche Médicale),Assistance Publique—Hopitaux De Paris,Universite Pierre et Marie Curie (PARIS 6)
- Current Assignee Address: FR Paris FR Paris FR Paris
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: EP11305269 20110311
- International Application: PCT/EP2012/054174 WO 20120309
- International Announcement: WO2012/123381 WO 20120920
- Main IPC: A61K38/20
- IPC: A61K38/20
Abstract:
The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
Public/Granted literature
- US20140004080A1 USE OF LOW DOSE IL-2 FOR TREATING AUTOIMMUNE - RELATED OR INFLAMMATORY DISORDERS Public/Granted day:2014-01-02
Information query
IPC分类:
